Intra-Cellular Therapies Inc

Intra-Cellular Therapies Inc


Market Cap$7.91B

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Intra-Cellular Therapies IncIntra-Cellular Therapies Inc00%-19.3-

Target Price by Analysts

26% upsideIntra-Cellular Therapies Target Price DetailsTarget Price

Current Fair Value

9.8% downside

Overvalued by 9.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$7.91 Billion
Enterprise Value-
Dividend Yield$0.0 (0.0%)
Earnings per Share$0.0
Outstanding Shares105,574,855
Avg 30 Day Volume1,682,422


Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio0.0
Price to Sales19.32
Price to Book Ratio-
Enterprise Value to Revenue-
Enterprise Value to EBIT-
Enterprise Value to Net Income0
Total Debt to Enterprise-
Debt to Equity-

Revenue Sources

No data

Insider Trades

ESG Score

No data

About Intra-Cellular Therapies Inc

CEO: Sharon Mates